Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Capital Leases: 2018

Historic Capital Leases for KalVista Pharmaceuticals (KALV) over the last 1 years, with Apr 2018 value amounting to $58,000.

  • KalVista Pharmaceuticals' Capital Leases was N/A to $58,000 in Q2 2018 from the same period last year, while for Apr 2018 it was $58,000, marking a year-over-year change of. This contributed to the annual value of $58,000 for FY2018, which is N/A change from last year.
  • According to the latest figures from FY2018, KalVista Pharmaceuticals' Capital Leases is $58,000.
  • In the past 5 years, KalVista Pharmaceuticals' Capital Leases registered a high of $58,000 during FY2018, and its lowest value of $58,000 during FY2018.
  • Over the past 1 years, KalVista Pharmaceuticals' median Capital Leases value was $58,000 (recorded in 2018), while the average stood at $58,000.